Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: DL likely welcomes this ITC result - could it also be the opposite?

I see your points and think they are valid, but couldn't this whole "ITC fiasco" be seen as another example for Leckrone's inability to monetize the MMP in an appropriate way?

Appropriate meaning in a reasonable period of time and efforts (money and working hours) and a reasonable risk/chance relation.

Share
New Message
Please login to post a reply